2.1 Failure to induce global/clinical remission |
8 |
526 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.90 [0.77, 1.04] |
2.1.1 5‐ASA / SASP < 1/2 |
1 |
29 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.90 [0.57, 1.41] |
2.1.2 1/1 > 5‐ASA / SASP ≥ 1/2 |
5 |
359 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.91 [0.77, 1.08] |
2.1.3 5‐ASA / SASP ≥ 1/1 |
3 |
138 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.85 [0.59, 1.23] |
2.2 Failure to induce global/clinical improvement (including remission) |
14 |
1053 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.88 [0.76, 1.01] |
2.2.1 5‐ASA / SASP < 1/2 |
3 |
123 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.77 [0.47, 1.27] |
2.2.2 1/1 > 5‐ASA / SASP ≥ 1/2 |
11 |
804 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.90 [0.77, 1.05] |
2.2.3 5‐ASA / SASP ≥ 1/1 |
3 |
126 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.81 [0.54, 1.22] |
2.3 Failure to induce endoscopic improvement (including remission) |
6 |
362 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.82 [0.65, 1.02] |
2.3.1 5‐ASA / SASP < 1/2 |
1 |
29 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.78 [0.58, 1.04] |
2.3.2 1/1 > 5‐ASA / SASP ≥ 1/2 |
4 |
246 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.73 [0.53, 1.02] |
2.3.3 5‐ASA / SASP ≥ 1/1 |
2 |
87 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.06 [0.72, 1.57] |
2.4 Adverse events |
12 |
909 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.48 [0.36, 0.63] |
2.4.1 5‐ASA / SASP < 1/2 |
1 |
56 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.35 [0.10, 1.20] |
2.4.2 1/1 > 5‐ASA / SASP ≥ 1/2 |
9 |
746 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.55 [0.41, 0.73] |
2.4.3 5‐ASA / SASP ≥ 1/1 |
2 |
107 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.16 [0.05, 0.52] |
2.5 Serious adverse events |
2 |
107 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.36 [0.28, 6.52] |
2.6 Withdrawals due to adverse events |
10 |
640 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.40 [0.24, 0.68] |
2.6.1 5‐ASA / SASP < 1/2 |
2 |
85 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.16 [0.02, 1.41] |
2.6.2 1/1 > 5‐ASA / SASP ≥ 1/2 |
5 |
361 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.67 [0.32, 1.39] |
2.6.3 5‐ASA / SASP ≥ 1/1 |
4 |
194 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.25 [0.10, 0.60] |
2.7 Exclusions and withdrawals after study entry |
10 |
701 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.76 [0.58, 0.99] |
2.7.1 5‐ASA / SASP < 1/2 |
1 |
29 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.10 [0.01, 1.80] |
2.7.2 1/1 > 5‐ASA / SASP ≥ 1/2 |
6 |
478 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.97 [0.71, 1.34] |
2.7.3 5‐ASA / SASP ≥ 1/1 |
4 |
194 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.44 [0.25, 0.77] |